CVS Health Corporation (CVS)
NYSE·Healthcare·Medical - Healthcare Plans
$81.09
+3.48%
Mkt Cap $97.43B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 10, 2026 | $103.70B | $105.69B | +1.92% | $1.00 | $1.09 | +9.00% | — | — |
| Q4 2025 Oct 29, 2025 | $98.81B | $102.87B | +4.11% | $1.37 | $1.60 | +16.79% | — | — |
| Q3 2025 Jul 31, 2025 | $94.53B | $98.92B | +4.64% | $1.46 | $1.81 | +23.97% | — | — |
| Q2 2025 May 1, 2025 | $93.68B | $94.59B | +0.97% | $1.70 | $2.25 | +32.35% | — | — |
| Q1 2025 Feb 12, 2025 | $97.09B | $97.71B | +0.64% | $0.91 | $1.19 | +30.20% | — | — |
| Q4 2024 Nov 6, 2024 | $92.75B | $95.43B | +2.89% | $1.44 | $1.09 | -24.31% | — | — |
| Q3 2024 Aug 7, 2024 | $91.41B | $91.23B | -0.19% | $1.73 | $1.83 | +5.78% | — | — |
| Q2 2024 May 1, 2024 | $89.33B | $88.44B | -1.00% | $1.70 | $1.31 | -22.94% | — | — |
| Q1 2024 Feb 7, 2024 | $90.36B | $93.81B | +3.82% | $2.01 | $2.12 | +5.47% | — | — |
| Q4 2023 Nov 1, 2023 | $88.25B | $89.76B | +1.72% | $2.13 | $2.21 | +3.76% | — | — |
| Q3 2023 Aug 2, 2023 | $86.53B | $88.92B | +2.76% | $2.12 | $2.21 | +4.25% | — | — |
| Q2 2023 May 3, 2023 | $80.81B | $85.28B | +5.52% | $2.07 | $2.20 | +6.28% | — | — |
| Q1 2023 Feb 8, 2023 | $76.43B | $83.85B | +9.70% | $1.92 | $1.99 | +3.65% | — | — |
| Q4 2022 Nov 2, 2022 | $76.74B | $81.16B | +5.76% | $1.99 | $2.09 | +5.03% | — | — |
| Q3 2022 Aug 3, 2022 | $76.41B | $80.64B | +5.53% | $2.17 | $2.40 | +10.60% | — | — |
| Q2 2022 May 4, 2022 | $75.54B | $76.83B | +1.71% | $2.15 | $2.22 | +3.26% | — | — |
| Q1 2022 Feb 9, 2022 | $75.66B | $76.60B | +1.25% | $1.94 | $1.98 | +2.06% | — | — |
| Q4 2021 Nov 3, 2021 | $70.34B | $73.79B | +4.91% | $1.79 | $1.97 | +10.06% | — | — |
| Q3 2021 Aug 4, 2021 | $70.30B | $72.62B | +3.30% | $2.06 | $2.42 | +17.48% | — | — |
| Q2 2021 May 4, 2021 | $68.34B | $69.10B | +1.11% | $1.72 | $2.04 | +18.60% | — | — |